Table 4

Results of adjusted models of relationship between symptoms and lung function abnormalities and exposure variables*

Health outcomeExposure variablesOR (95% CI)
Symptom
 SinusitisUse flavourings ingredients1.5 (1.0 to 2.4)
Use cleaning products1.3 (0.8 to 2.1)
 WR sinusitisTime in production areas1.7 (0.8 to 3.5)
Use flavourings ingredients1.9 (0.9 to 4.2)
Use cleaning products3.0 (1.3 to 8.0)
 Nasal symptomsUse flavourings ingredients1.4 (0.9 to 2.2)
Use cleaning products1.5 (0.9 to 2.4)
 WR nasal symptomsTime in production areas1.2 (0.6 to 2.3)
Use flavourings ingredients2.2 (1.1 to 4.5)
Use cleaning products2.1 (1.0 to 4.6)
 Asthma-like symptomsTime in production areas1.5 (0.9 to 2.4)
 Shortness of breathTenure2.0 (1.1 to 3.6)
 WR wheezeTime in production areas1.8 (0.7 to 5.0)
Use flavourings ingredients2.1 (0.7 to 6.7)
Use cleaning products2.0 (0.6 to 7.7)
 WR breathing troubleTime in production areas2.7 (1.1 to 7.1)
Use flavourings ingredients2.8 (1.1 to 7.7)
 Usual phlegmTime in production areas2.2 (1.2 to 4.0)
Use flavourings ingredients1.4 (0.7 to 2.8)
Use cleaning products1.5 (0.7 to 3.0)
 Usual coughTime in production areas1.9 (1.0 to 3.7)
 WR usual coughTime in production areas1.8 (0.5 to 7.6)
Use flavourings ingredients4.7 (1.1 to 33)
Lung function abnormality
 Any spirometric abnormalityTime in production areas2.3 (1.1 to 5.3)
 Low diffusing capacityTime in production areas2.8 (0.9 to 9.4)
  • Statistically significant associations are shown in bold.

  • *Each model includes the exposure variables associated with the health outcome in univariable analyses. Wheeze and breathing trouble were not included in this table as they were not associated with the exposure variables in univariable analyses. Models of symptoms are adjusted for age and smoking status. Models of lung function abnormalities are adjusted for smoking status.

  • WR, work related.